$ISRG +1.14% Starts Repairing the Damage From Its 2026 Slide

Trend_Radar
18:46

$Intuitive Surgical(ISRG)$

$Intuitive Surgical(ISRG) +1.14% Reclaims $376 Pivot, MACD Inflection Building Toward $452 Resistance

Latest Close Data ISRG closed at $376.86 on Sep 01, +1.14% (+$4.26), recovering from an intraday low of $365.32 to a high of $377.37. Price now sits 37.6% below its 52-week high of $603.88, with $452.02 identified as immediate overhead resistance.

Core Market Drivers Medical device sentiment remains fragile, but rotation into robotic surgery is firming. UBS recently upgraded ISRG to Buy with a $500 target, citing overdone automation-risk fears, while the company's Q2 adjusted EPS of $2.80 beat consensus by 12%. Plans for a new 316,000 sq ft Malaysia manufacturing facility (2028 startup) underpin global da Vinci expansion.

Technical Analysis Volume of 1.9236M shares ran slightly above the 5-day average, supporting today's bounce. MACD remains negative (-2.60) but DIF (-1.32) is converging sharply on DEA (-0.02) — a bullish inflection is forming from deeply oversold conditions. RSI(6) jumped to 50.18, crossing the midline, while RSI(12) at 48.54 confirms momentum repair. KDJ also flipped bullish with J at +13.05.

Key Price Levels

  • Primary Support: $357.81 (Aug 31 swing low)

  • Strong Resistance: $452.02 (recent structural ceiling)

  • Immediate Pivot: $376.86 — reclaiming this level opens path toward $390 psychological zone

  • A close below $357.81 would invalidate the rebound and target $328.57 (52-week low)

Valuation Perspective P/E TTM of 43.22 trades at a sharp discount to its historical forward P/E average of 59.59, while P/S of 12.11 reflects premium quality. Forward P/E of 34.52 sits well below the -1σ band (47.84), signaling valuation compression.

Analyst Targets Among 29 analysts, the average target is $480.77, with 11 Strong Buys and 13 Buys versus only 9 Holds and 1 Underperform. The range spans $324 to $685, skewed decisively upward.

Weekly Outlook Expect a volatile consolidation between $358–$390. A decisive break above $390 could trigger short-covering toward $410–$420. Failure to hold $358 would expose $328.57 lows. 🩺📈

⚠️ Risk Disclaimer: This is for informational purposes only and does not constitute investment advice. Markets involve risk; past performance does not guarantee future results.

🎯$Intuitive Surgical(ISRG) Options Strategy: Bull Call Spread (Debit Spread) – Oversold Bounce & MACD Inflection

  • Underlying: ISRG (Intuitive Surgical Inc.)

  • Market View: Cautiously bullish / oversold rebound toward $390–$410, supported by analyst targets and positive MACD convergence.

  • Strategy Type: Bull Call Debit Spread – directional, limited risk, positive theta (if near expiry), negative vega but mitigated by moderate IV percentile.

  • Option Contract Portfolio:

    • Buy 1 ISRG 2026-09-11 380 Call @ $4.45 (mid)

    • Sell 1 ISRG 2026-09-11 400 Call @ $0.15 (mid)

    • Net Debit = $4.30 per share ($430 per contract)

  • Maximum Gain & Loss:

    • Max Gain = (400 – 380) – 4.30 = $15.70 per share ($1,570 per contract)

    • Max Loss = $4.30 per share ($430 per contract)

  • Initial Cost/Credit: Net Debit of $4.30 (cash outlay)


Investing is a long journey. Knowing when to move matters — and so does knowing when to recharge.

Markets may not slow down, but you can. Whether it’s a quick break between trading sessions or a long journey, staying comfortable helps you reset for what comes next. The new Night Trading Memory Foam Pillow features 360° ergonomic support and slow-rebound memory foam that gently conforms to your neck, plus a roll-up design that makes it easy to bring wherever you go.

https://laohu8.com/J/redeemGift?goodID=100540&type=delivery

Redeem the new Night Trading Memory Foam Pillow in Tiger Coins Mall, and stay supported for the journey ahead.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment